Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?

Overview of attention for article published in Oncotarget, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 6 news outlets
blogs: 2 blogs
twitter: 2 X users

facebook: 1 Facebook page
reddit: 1 Redditor
video: 1 YouTube creator

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary News Blogs X Facebook Reddit YouTube Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 15,438 followers.

RT @Oncotarget: #PaperoftheDay: "Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so…

22 Nov 2023

Reply Repost Favourite

#PaperoftheDay: "Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?" DOI: https://t.co/oPweJxR9f9 #cancerresearch #oncology #MedEd

22 Nov 2023

Reply Repost Favourite

#PaperSpotlight: On July 7, 2023, researchers from @wearemedsir published a new editorial paper in #Oncotarget, entitled, “Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?” DOI: https://t.co/v4

13 Sep 2023

Reply Repost Favourite

NEW #PaperoftheDay: "Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?" https://t.co/v4Er1XPIaP #cancerresearch #oncology #OA #MedEd

10 Jul 2023

Reply Repost Favourite

Oncotarget

Article Metrics

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?

About this Attention Score

Mentioned by

Citations

Readers on